权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

ASBMR Three Year Symposia

ASBMR 三年研讨会

基本信息

批准号：
9321912
负责人：
DOUGLAS P. KIEL
金额：
$ 4万
依托单位：
AMERICAN SOCIETY FOR BONE & MINERAL RES
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-08-01 至 2019-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9321912
关键词：
Academia Address Affect American Animal Model Area Biological Markers Biomechanics Bone structure Cartilage Cartilage Diseases Cells Clinical Clinical Research Complex Data Degenerative polyarthritis Diné Nation Disease Fracture Functional disorder Funding Genomics Goals Government Grant Image Incidence Industry Joints Laboratories Medical Societies Metabolism Methods Minerals Molecular Biology Morbidity - disease rate Musculoskeletal Diseases Osteoporosis Patient Care Patients Physiology Professional Organizations Recording of previous events Research Research Personnel Scientific Societies Scientist Serum Skeleton Societies State-of-the-Art Reviews Surrogate Markers Time Translating Underrepresented Minority United States National Institutes of Health Woman base bone bone fragility bone quality burden of illness clinical application cost disability burden fracture risk improved in vivo joint destruction meetings men mortality precision medicine prevent skeletal skeletal disorder symposium translation to humans

项目摘要

The American Society for Bone and Mineral Research (ASBMR), the largest professional, scientific and medical society established to bring together clinical and laboratory-based scientists who are involved in the study of bone and mineral metabolism, has had a successful history of conducting annual topical meetings funded by single year NIH R13 grants since 2002. This application seeks funding for a three year R13 grant to advance the field of skeletal diseases by focusing on three specific areas of scientific research: 1) skeletal genomics (“Bone-omics–Translating Genomic Discoveries into Clinical Applications”); 2) bone fragility (“Current Concepts in Bone Fragility: From Cells to Surrogates”); 3) skeletal contributions to the pathophysiology and clinical manifestations of osteoarthritis (“Skeletal Contributions to Joint Degeneration and Osteoarthritis”). These three areas cover a range of topics that collectively contribute to a majority of the clinical morbidity and mortality of skeletal disease. The overall objective of this R13 is to stimulate further advances that will result in improved patient care for skeletal diseases by bringing together the best researchers for each of the three symposia that will be held in conjunction with the annual meetings of the ASBMR. Each of the three symposia will review the state of the art in each topic area, exchanging ideas with attendees, and stimulating the interaction between young and established researchers. For each of the three symposia, attendees will be encouraged to attend the subsequent ASBMR Annual Meetings for additional opportunities to interact with bone researchers. Agendas for all three years have been developed by an organizing committee with committed speakers for the first two years. The agendas include established and young investigators, men, women and underrepresented minority speakers. At the end of each meeting, a “dine-around” evening is planned to allow direct interaction between young investigators and more senior speakers at the meeting. In 2016, the symposium will appraise the latest contributions of the field of genomics to the understanding of skeletal disease mechanisms, ranging from basic molecular biology to animal models and bidirectional translation to humans, particularly within the scope of precision medicine and targeted treatments. The 2017 symposium will discuss the latest research on the mechanisms underlying skeletal fragility and state-of-the-art methods to assess fracture risk. In addition, new data supporting the use of surrogate markers for fracture will be discussed. The 2018 symposium will promote interaction among basic, translational and clinical researchers in skeletal and osteoarthritis research, with a focus on recent data emerging on cartilage-bone structure and physiology within articulating joints.

美国骨与矿物研究协会（ASBMR）是美国最大的专业、科学和科学组织